Display Settings:

Format

Send to:

Choose Destination
    Ther Clin Risk Manag. 2009 Jun;5(3):661-9. Epub 2009 Aug 20.

    Prophylatic treatment of migraine and migraine clinical variants with topiramate: an update.

    Source

    Department of Neuro-otology and Pain and Headache, Instituto de Neurociencias de Buenos Aires INEBA, Buenos Aires, Argentina;

    Abstract

    Migraine and migraine variants are common, chronic and incapacitating neurovascular disorders with a high impact on health resources. There is an extensive evidence base provided by double-blind, placebo-controlled trials showing that topiramate is a safe, effective and well tolerated drug in the management of migraine and its variants, being especially promising in the management of migraine-vertigo syndrome. Models both in the US and the UK have also shown that it offers a cost benefit when direct and indirect costs are evaluated, by reducing work loss, improving quality of life and reducing the use of increasingly scarce health resources.

    PMID:
    19707282
    [PubMed]
    PMCID:
    PMC2731022
    Free PMC Article

      Supplemental Content

      Icon for Dove Medical Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk